title: Variability of marker-based rectal dose evaluation in HDR cervical brachytherapy.
abstract: In film-based intracavitary brachytherapy for cervical cancer, position of the rectal markers may not accurately represent the anterior rectal wall. This study was aimed at analyzing the variability of rectal dose estimation as a result of interfractional variation of marker placement. A cohort of five patients treated with multiple-fraction tandem and ovoid high-dose-rate (HDR) brachytherapy was studied. The cervical os point and the orientation of the applicators were matched among all fractional plans for each patient. Rectal points obtained from all fractions were then input into each clinical treated plan. New fractional rectal doses were obtained and a new cumulative rectal dose for each patient was calculated. The maximum interfractional variation of distances between rectal dose points and the closest source positions was 1.1 cm. The corresponding maximum variability of fractional rectal dose was 65.5%. The percentage difference in cumulative rectal dose estimation for each patient was 5.4%, 19.6%, 34.6%, 23.4%, and 13.9%, respectively. In conclusion, care should be taken when using rectal markers as reference points for estimating rectal dose in HDR cervical brachytherapy. The best estimate of true rectal dose for each fraction should be determined by the most anterior point among all fractions.
authors: Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. Zhou.Wang@RoswellPark.org
authors: Zhou
authors: Z
authors: Wang
authors: Wainwright
authors: W
authors: Jaggernauth
authors: Harish K
authors: HK
authors: Malhotra
authors: Matthew B
authors: MB
authors: Podgorsak
mesh_terms: D001822:Body Burden; D001918:Brachytherapy / Q000379:methods*; D005260:Female; D006801:Humans; D009928:Organ Specificity; D011874:Radiometry / Q000379:methods*; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods*; D012007:Rectum; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D002583:Uterine Cervical Neoplasms / Q000532:radiotherapy*